GRAIL, LLC (GRAL NASDAQ) stock market data APIs
$157.7373
-6.02(-3.8%)
as of October 28, 2026
Try our APIs with
free plan!
GRAIL, LLC Financial Data Overview
Price chart is built with
Anychart
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prev. Close
157.7373
Open
151.7198
High
160.9791
Low
150.7198
52 wk Range
41.5-166.475
Market Cap
7 052 M
Shares Outstanding
44 666 K
Revenue
165 M
EPS
-2.56
Beta
2.838
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GRAIL, LLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GRAIL, LLC data using free add-ons & libraries
Get GRAIL, LLC Fundamental Data
GRAIL, LLC Fundamental data includes:
- Net Revenue: 165 M
- EBITDA: -378 488 992
- Earnings Per Share: -10
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-05
- EPS/Forecast: -2.91
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GRAIL, LLC News
New
IBD Stock Of The Day, Natera, Hovering Near Buy Point
Natera is Thursday's IBD Stock Of The Day. Shares are hovering around their 21-day line, taking a breather after running up. Continue Reading
GRAIL (GRAL) Stock Sees Fair Value Lift After Analysts Back Galleri Outlook
GRAIL's updated analyst fair value estimate has shifted from US$97.40 to US$131.30, which is a meaningful reset in how the stock is being framed. The change aligns with recent Street commentary that h...
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
GRAIL, Inc. (NASDAQ:GRAL) traded at around $133 on October 7, down 3.19% on the day, though still 93.00% higher over twelve months. Guardant Health, Inc. (NASDAQ:GH) traded near $168 over the same ses...
What's next for personalized mRNA cancer vaccines?
[mrna Cancer Vaccine] wildpixel/iStock via Getty Images INVESTORS SHOULD KNOW: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma into a broader test a...
Get GRAIL, LLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.